Canada markets close in 4 hours 46 minutes

ImmunoPrecise Antibodies Ltd. (IPA.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
9.51+0.01 (+0.11%)
As of 10:24AM EDT. Market open.
Currency in CAD

Valuation Measures

Market Cap (intraday) 5181.44M
Enterprise Value 3169.2M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)10.56
Price/Book (mrq)5.05
Enterprise Value/Revenue 39.85
Enterprise Value/EBITDA 7-41.81

Trading Information

Stock Price History

Beta (5Y Monthly) -0.12
52-Week Change 31,072.84%
S&P500 52-Week Change 341.30%
52 Week High 326.25
52 Week Low 30.81
50-Day Moving Average 312.05
200-Day Moving Average 314.29

Share Statistics

Avg Vol (3 month) 354.07k
Avg Vol (10 day) 349.12k
Shares Outstanding 519.08M
Implied Shares Outstanding 6N/A
Float 17.03M
% Held by Insiders 16.75%
% Held by Institutions 16.14%
Shares Short (Apr. 29, 2021) 445.1k
Short Ratio (Apr. 29, 2021) 41.34
Short % of Float (Apr. 29, 2021) 4N/A
Short % of Shares Outstanding (Apr. 29, 2021) 40.24%
Shares Short (prior month Mar. 30, 2021) 431.52k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 390,000.00
Trailing Annual Dividend Yield 3947,368.46%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov. 22, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Nov. 22, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr. 29, 2020
Most Recent Quarter (mrq)Jan. 30, 2021

Profitability

Profit Margin -18.93%
Operating Margin (ttm)-31.16%

Management Effectiveness

Return on Assets (ttm)-9.67%
Return on Equity (ttm)-13.93%

Income Statement

Revenue (ttm)17.18M
Revenue Per Share (ttm)1.13
Quarterly Revenue Growth (yoy)11.90%
Gross Profit (ttm)7.95M
EBITDA -4.05M
Net Income Avi to Common (ttm)-3.25M
Diluted EPS (ttm)-0.21
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.72M
Total Cash Per Share (mrq)0.82
Total Debt (mrq)3.67M
Total Debt/Equity (mrq)11.37
Current Ratio (mrq)3.39
Book Value Per Share (mrq)1.88

Cash Flow Statement

Operating Cash Flow (ttm)595.17k
Levered Free Cash Flow (ttm)776.89k